Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages our CELsignia CDx platform.

Lance Laing
Chief Science Officer & Co-Founder
Vicky Hahne
Eric Lindquist
Chief Business Officer
Arthur DeCillis
Chief Medical Officer
John R. MacDonald
SVP of R&D
Sheri Smith
Head of Clinical Operations
Marie DeGayner Kuker
Head of Regulatory
Bernhard Lampert
Head of CMC
Igor Gorbatchevsky
VP, Clinical Development
Jill Krause
VP, Clinical Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.